Dedifferentiated Liposarcoma (DDLPS)

2

Review clinical trials related to Dedifferentiated Liposarcoma (DDLPS). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma

A study of lifileucel (tumor-infiltrating lymphocytes) in adults with advanced soft tissue sarcoma ('SARATOGA')

Participants needed: 80
Trial details
Phase: Phase 2Age: 16-70Biological sex: AllType: InterventionalSponsor: Iovance Biotherapeutics, Inc.Updated: Oct 9, 2026Locations: 2
Eligibility criteria

Participant must be ≥ 16 years of age at the time of signing the informed consen... [+11]

Participant has symptomatic untreated brain metastases. [+5]

Status: Not yet recruiting

Doxorubicin With or Without DT-7012 in Advanced Soft Tissue Sarcoma

The primary objective of this randomized phase II trial is to assess, independently in advanced/metastatic UPS and DDLPS, the antitumor activity of DT-7012 combined with doxorubicin as first-line systemic therapy.

Participants needed: 80
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Gustave Roussy, Cancer Campus, Grand ParisUpdated: Sep 15, 2026Locations: 1
Eligibility criteria

Age ≥ 18 years at the time of signature of the informed consent form. [+26]

Diagnosis of a sarcoma subtype other than UPS or DDLPS, including well-different... [+24]